New Managing Director for subsidiary Osstell
Gothenburg, Sweden, March 31, 2010
New Managing Director for Biolin Scientific’s subsidiary Osstell
Jonas Ohlsson has been appointed as the new Managing Director and President of Osstell AB.
Jonas Ohlsson has been appointed as the new Managing Director and President of Osstell AB. Jonas Ohlsson has had previous CEO assignments for more than 10 years in several international medtech and life science companies, focused on innovative technologies and products. Jonas Ohlsson has previously been working in companies such as Mentice and Applied Biosystems. Jonas Ohlsson succeeds Anders Peterson, who has been the managing director since year 2000. Anders Petersson will continue with Osstell in a new role, focusing on development and production activities.
”Jonas Ohlsson is a driven entrepreneur with a strong track record. We are convinced that he is the right person to lead Osstell, which is ready to increase its growth and focus on expansion. Anders Peterson has done an excellent job to create an innovative company with unique products.” says Fredrik Lindgren, CEO for Biolin Scientific.
”Osstell is an exciting company with the technology and products that brings opportunities for improved dental implant surgery. I am looking forward to being part of Osstell and to develop it further with sustainable and profitable growth. The company is well positioned for the future, following the focused and persistent efforts in product development and establishment of crucial key opinion leader relationships.” says Jonas Ohlsson, new Managing Director in Osstell.
For further information, please contact:
Fredrik Lindgren, CEO of Biolin Scientific, email@example.com
CEO of BiolinScientific AB (publ)
+46 705-61 61 77
|COMPANY INFORMATION |
BiolinScientific AB (publ)
SE-426 77 Västra Frölunda
Telephone: +46 31 769 7690
Fax: +46 31 69 80 40
Company number: 556249-4293
Nasdaq OMX Small Cap in Sweden
Stock ticker: BLIN
BIOLINSCIENTIFIC IN BRIEF
BiolinScientific is an analytical instruments provider focused on the nano-scale study of interfaces within materials research and bioscience. Our customers are scientists and researchers in academic research, research institutes and the industrial sector.